AMANDA MILLER: Open Payments
NPI 1679183610 · ACKERMAN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$221 in 6 payments from 4 companies in 2025. Trend: 2023 $200 · 2024 $453 · 2025 $221
Food & beverage: $221
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| Novo Nordisk Inc | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: Kerendia, FARXIGA, Ozempic, CAPLYTA.
Industry payments across MS — which companies pay providers there.
